Evidence map›Paper›PMID 37200035›Full record

SynthesisJAMA network open2023

Comparison of Anti-Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis.

Brigida Anna Maiorano, Davide Ciardiello, Evaristo Maiello, Giandomenico Roviello

Open access · goldAbstract readMeta-AnalysisLetter
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. First-line ICIs in renal cell carcinoma.Human vaccines & immunotherapeutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Brigida Anna MaioranoOncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Davide CiardielloDepartment of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy.
Evaristo MaielloOncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Giandomenico RovielloDepartment of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
Casa Sollievo della Sofferenza · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsB7-H1 AntigenHumansSunitinibB7-H1 AntigenCD274 protein, humanSunitinib

Identifiers

PMID37200035
PMCPMC10196874
OpenAlexW4377011652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.